Understanding how Ing4 deficiency can improve blood cell regeneration
Ing4-deficiency enhances the regenerative capacity of multipotent progenitor cells
This study is looking at a protein called Ing4 to see how it affects blood stem cells, with the goal of finding better ways to help patients who need blood cell transplants.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10574574 on NIH RePORTER |
What this research studies
This research investigates the role of Ing4, a protein that influences the behavior of hematopoietic stem cells (HSCs), which are crucial for producing blood cells. The study aims to enhance the self-renewal and differentiation of these stem cells to improve outcomes for patients undergoing hematopoietic stem cell transplantation. By using advanced genetic screening techniques, the researchers are exploring how the absence of Ing4 affects blood cell production in mice, with the hope of translating these findings to better treatments for patients with blood disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with blood disorders, particularly those requiring hematopoietic stem cell transplants.
Not a fit: Patients with conditions unrelated to blood cell production or those not requiring stem cell transplants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and outcomes for patients receiving stem cell transplants.
How similar studies have performed: Previous research has shown promising results in enhancing stem cell function through genetic modifications, indicating potential for success in this approach.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Kathrein, Katie L — University of South Carolina at Columbia
- Study coordinator: Kathrein, Katie L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.